The Oncology Institute closed its business combination with DFP Healthcare Acquisitions .
The combined company’s stock and warrants trade on the Nasdaq under the new ticker symbols “TOI” and “TOIIW”.
The transaction implies an enterprise value for TOI of $842 million. TOI raised approximately $334 million of cash proceeds through the merger, which includes $275 million from a PIPE. Approximately $133 million will be retained on TOI’s balance sheet to fund growth initiatives, including de novo clinics and acquisitions. Read more.
